Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction.

MLA

Karatas, Hacer, et al. “Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction.” Journal of Medicinal Chemistry, vol. 60, no. 12, June 2017, p. 1. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.6b01796.

APA

Karatas, H., Yangbing Li, Liu Liu, Jiao Ji, Lee, S., Yong Chen, Jiuling Yang, Liyue Huang, Bernard, D., Jing Xu, Townsend, E. C., Fang Cao, Xu Ran, Xiaoqin Li, Wen, B., Duxin Sun, Stuckey, J. A., Ming Lei, Yali Dou, & Shaomeng Wang. (2017). Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction. Journal of Medicinal Chemistry, 60(12), 1. https://doi.org/10.1021/acs.jmedchem.6b01796

Chicago

Karatas, Hacer, Yangbing Li, Liu Liu, Jiao Ji, Shirley Lee, Yong Chen, Jiuling Yang, et al. 2017. “Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction.” Journal of Medicinal Chemistry 60 (12): 1. doi:10.1021/acs.jmedchem.6b01796.